Bayer's investigational stroke drug asundexian met both efficacy and safety goals in the Phase III OCEANIC-STROKE trial. The ...

FRANKFURT, Feb 5 (Reuters) - Bayer said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% ...

Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. The Food and Drug Administration approved the drug — also known by ...

BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today ...

Bayer AG’s proposed purchase of Merck & Co.’s consumer health unit would create a combined over-the-counter business with many of the products in a typical medicine chest. Sales in 2013 for the top ...

Yosi Health has named Lori Ryan the Director of Customer Success, and Patrick McInnis is joining the organization as the Vice President of Partnerships. Precision for Medicine has hired Margaret ...